RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 501.00
-13.00 (-2.53%)
Jun 3, 2026, 3:30 PM JST
RaQualia Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 284.22 | 437 | -357 | -294 | 851 | 880 |
Depreciation & Amortization | 479.15 | 487 | 401 | 175 | 147 | 141 |
Loss (Gain) From Sale of Investments | - | - | -3 | - | 35 | -16 |
Other Operating Activities | -268.75 | -131 | -100 | -128 | -203 | -81 |
Change in Accounts Receivable | -79.16 | -1,239 | -85 | - | 603 | -674 |
Change in Inventory | -0.85 | 7 | 3 | -139 | 2 | -4 |
Change in Accounts Payable | 31.03 | 76 | -98 | -134 | 111 | 136 |
Change in Other Net Operating Assets | -286.62 | 9 | 419 | -198 | -66 | -16 |
Operating Cash Flow | 203.4 | -354 | 180 | -718 | 1,480 | 366 |
Operating Cash Flow Growth | -30.28% | - | - | - | 304.37% | - |
Capital Expenditures | -65.56 | -67 | -96 | -205 | -31 | -92 |
Cash Acquisitions | -120 | - | -3,879 | - | - | - |
Sale (Purchase) of Intangibles | -7 | -7 | -19 | -17 | - | -13 |
Investment in Securities | 54 | 200 | 158 | 90 | -15 | -174 |
Other Investing Activities | -6 | -2 | 171 | -3 | -1 | - |
Investing Cash Flow | -144.56 | 124 | -3,665 | -135 | -47 | -279 |
Short-Term Debt Issued | - | - | 400 | - | - | 10 |
Long-Term Debt Issued | - | - | 3,357 | 50 | 13 | - |
Total Debt Issued | - | - | 3,757 | 50 | 13 | 10 |
Short-Term Debt Repaid | - | - | -400 | - | - | -10 |
Long-Term Debt Repaid | - | -512 | -387 | -11 | -2 | - |
Total Debt Repaid | -493.77 | -512 | -787 | -11 | -2 | -10 |
Net Debt Issued (Repaid) | -493.77 | -512 | 2,970 | 39 | 11 | - |
Issuance of Common Stock | 2,421 | 1,019 | 80 | 805 | 4 | 1 |
Other Financing Activities | -98.8 | -129 | -68 | -51 | -44 | -17 |
Financing Cash Flow | 1,828 | 378 | 2,982 | 793 | -29 | -16 |
Foreign Exchange Rate Adjustments | 43.23 | -45 | -20 | 45 | 35 | 109 |
Miscellaneous Cash Flow Adjustments | -1 | -1 | 1 | 1 | -1 | -1 |
Net Cash Flow | 1,930 | 102 | -522 | -14 | 1,438 | 179 |
Free Cash Flow | 137.84 | -421 | 84 | -923 | 1,449 | 274 |
Free Cash Flow Growth | -32.47% | - | - | - | 428.83% | - |
Free Cash Flow Margin | 3.61% | -10.58% | 2.70% | -48.55% | 49.66% | 9.87% |
Free Cash Flow Per Share | 5.52 | -17.50 | 3.88 | -42.72 | 69.06 | 13.06 |
Cash Interest Paid | 59.52 | 59 | 42 | 6 | 6 | 1 |
Cash Income Tax Paid | 209.25 | 138 | 100 | 109 | 183 | 76 |
Levered Free Cash Flow | - | -485 | 415.63 | -694 | 1,172 | 64.88 |
Unlevered Free Cash Flow | - | -448.13 | 441.88 | -689.63 | 1,176 | 65.5 |
Change in Working Capital | -290.9 | -1,147 | 239 | -471 | 650 | -558 |